147 related articles for article (PubMed ID: 17499129)
1. Positron emission tomography: poor sensitivity for occult tonsillar cancer.
Nabili V; Zaia B; Blackwell KE; Head CS; Grabski K; Sercarz JA
Am J Otolaryngol; 2007; 28(3):153-7. PubMed ID: 17499129
[TBL] [Abstract][Full Text] [Related]
2. Utility of quantitative 18 F-fluorodeoxyglucose uptake measurement to identify occult tonsillar carcinoma in patients with cervical metastasis of unknown primary tumours: a retrospective case-control study.
Lee HJ; Kim JS; Roh JL; Lee JH; Cho KJ; Park GC; Choi SH; Nam SY; Kim SY
Clin Otolaryngol; 2013 Feb; 38(1):30-8. PubMed ID: 23167514
[TBL] [Abstract][Full Text] [Related]
3. Squamous cell carcinoma of the palatine tonsils: FDG standardized uptake value ratio as a biomarker to differentiate tonsillar carcinoma from physiologic uptake.
Davison JM; Ozonoff A; Imsande HM; Grillone GA; Subramaniam RM
Radiology; 2010 May; 255(2):578-85. PubMed ID: 20413767
[TBL] [Abstract][Full Text] [Related]
4. Positron emission tomography in the management of unknown primary head and neck carcinoma.
Miller FR; Hussey D; Beeram M; Eng T; McGuff HS; Otto RA
Arch Otolaryngol Head Neck Surg; 2005 Jul; 131(7):626-9. PubMed ID: 16027287
[TBL] [Abstract][Full Text] [Related]
5. PET/CT findings within the contralateral tonsil following unilateral tonsillectomy.
Hirshoren N; Olayos E; Callahan J; Lau E
Laryngoscope; 2016 Nov; 126(11):2480-2483. PubMed ID: 27114188
[TBL] [Abstract][Full Text] [Related]
6. Histogram Analysis of Apparent Diffusion Coefficients for Occult Tonsil Cancer in Patients with Cervical Nodal Metastasis from an Unknown Primary Site at Presentation.
Choi YJ; Lee JH; Kim HO; Kim DY; Yoon RG; Cho SH; Koh MJ; Kim N; Kim SY; Baek JH
Radiology; 2016 Jan; 278(1):146-55. PubMed ID: 26115452
[TBL] [Abstract][Full Text] [Related]
7. Role of 18-Fludeoxyglucose positron emission tomography-computed tomography and subsequent panendoscopy in head and neck squamous cell carcinoma of unknown primary.
Mani N; George MM; Nash L; Anwar B; Homer JJ
Laryngoscope; 2016 Jun; 126(6):1354-8. PubMed ID: 26671043
[TBL] [Abstract][Full Text] [Related]
8. F-18 FDG PET/CT in primary tonsillar lymphoma.
Zhang MJ; Jiang JJ; Jiang MS; He W
Clin Nucl Med; 2010 Sep; 35(9):710-2. PubMed ID: 20706049
[TBL] [Abstract][Full Text] [Related]
9. Synchronous bilateral tonsillar carcinoma: role of fluoro-deoxyglucose positron emission tomography scanning in detecting occult primary tumours in metastatic nodal disease of the head and neck.
Price T; Pickles J
J Laryngol Otol; 2006 Apr; 120(4):334-7. PubMed ID: 16623981
[TBL] [Abstract][Full Text] [Related]
10. Impact of [18F]-2-fluorodeoxyglucose-positron emission tomography/computed tomography on previously untreated head and neck cancer patients.
Fleming AJ; Smith SP; Paul CM; Hall NC; Daly BT; Agrawal A; Schuller DE
Laryngoscope; 2007 Jul; 117(7):1173-9. PubMed ID: 17603315
[TBL] [Abstract][Full Text] [Related]
11. Palatine tonsil SUVmax on FDG PET-CT as a discriminator between benign and malignant tonsils in patients with and without head and neck squamous cell carcinoma of unknown primary.
Pencharz D; Dunn J; Connor S; Siddiqui A; Sriskandan N; Thavaraj S; Jeannon JP; Oakley R; Lei M; Guerrero-Urbano T; Cook GJ; Szyszko TA
Clin Radiol; 2019 Feb; 74(2):165.e17-165.e23. PubMed ID: 30454841
[TBL] [Abstract][Full Text] [Related]
12. Role of tonsillectomy in the search for a squamous cell carcinoma from an unknown primary in the head and neck.
Kothari P; Randhawa PS; Farrell R
Br J Oral Maxillofac Surg; 2008 Jun; 46(4):283-7. PubMed ID: 18243447
[TBL] [Abstract][Full Text] [Related]
13. Role of 18F-FDG PET in detecting primary site in the patient with primary unknown carcinoma.
Yabuki K; Tsukuda M; Horiuchi C; Taguchi T; Nishimura G
Eur Arch Otorhinolaryngol; 2010 Nov; 267(11):1785-92. PubMed ID: 20814690
[TBL] [Abstract][Full Text] [Related]
14. Use, accuracy, and implications for patient management of [18F]-2-fluorodeoxyglucose-positron emission/computerized tomography for head and neck tumors.
Zanation AM; Sutton DK; Couch ME; Weissler MC; Shockley WW; Shores CG
Laryngoscope; 2005 Jul; 115(7):1186-90. PubMed ID: 15995504
[TBL] [Abstract][Full Text] [Related]
15. Utility of 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography and positron emission tomography/computed tomography imaging in the preoperative staging of head and neck squamous cell carcinoma.
Roh JL; Yeo NK; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
Oral Oncol; 2007 Oct; 43(9):887-93. PubMed ID: 17207656
[TBL] [Abstract][Full Text] [Related]
16. The role of 18F-fluoro-2-deoxyglucose positron emission tomography/computed tomography in the management of patients with carcinoma of unknown primary.
Deonarine P; Han S; Poon FW; de Wet C
Scott Med J; 2013 Aug; 58(3):154-62. PubMed ID: 23960054
[TBL] [Abstract][Full Text] [Related]
17. The role of tonsillectomy in the initial diagnostic work-up of head and neck squamous cell carcinoma of unknown primary.
Berta E; Atallah I; Reyt E; Boyer E; Karkas A; Righini CA
Eur Ann Otorhinolaryngol Head Neck Dis; 2014 Nov; 131(5):305-8. PubMed ID: 25443689
[TBL] [Abstract][Full Text] [Related]
18. Role of 2-[18F] fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography in the post-therapy surveillance of breast cancer.
Chang HT; Hu C; Chiu YL; Peng NJ; Liu RS
PLoS One; 2014; 9(12):e115127. PubMed ID: 25517451
[TBL] [Abstract][Full Text] [Related]
19. Unknown primary tumors: detection with dual-modality PET/CT--initial experience.
Gutzeit A; Antoch G; Kühl H; Egelhof T; Fischer M; Hauth E; Goehde S; Bockisch A; Debatin J; Freudenberg L
Radiology; 2005 Jan; 234(1):227-34. PubMed ID: 15564390
[TBL] [Abstract][Full Text] [Related]
20. A case of three synchronous primary tumors demonstrated by F-18 FDG PET.
Mittra E; Vasanawala M; Niederkohr R; Rodriguez C; Segall G
Clin Nucl Med; 2007 Aug; 32(8):666-7. PubMed ID: 17667450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
